Medicinal
mushrooms: their therapeutic properties and current medical usage
with special emphasis on cancer treatments.

Authors:
JOHN E SMITH BSc MSc PhD DSc FIBiol FRSE
Emeritus Professor of Applied Microbiology, University of Strathclyde
Chief Scientific Officer, MycoBiotech Ltd, Singapore
NEIL J ROWAN BSc MSc PhD MIBiol MIFST
Lecturer, Department of Bioscience, University of Strathclyde
RICHARD SULLIVAN BSc MD PhD
Head of Clinical Programmes, Cancer Research UK
Introduction
Many of the currently available anti-cancer agents are derived form natural
products, for instance paclitaxel (Taxol), and camptothecin (Hycamtin) amongst
many others. In 2000 Professor Gordon McVie, Director-General of the Cancer
Research Campaign (now Cancer Research UK) and Professor John Smith of University
of Strathclyde met in Glasgow to discuss the role of medicinal mushrooms
in the treatment of cancer. The CRC had become aware that these natural products
were being used extensively in the Far East as nutriceuticals (dietary supplements)
and as a source for the generation of pharmaceutical-grade medicines to treat
a wide variety of diseases, including cancer. The substantial range of medicinal
mushroom species from which different bioactive compounds can be derived
suggested that the humble mushroom could be a source of novel anti-cancer
agents.
This monograph is a comprehensive overview of this subject from the technology
of cultivation, extraction and chemistry of medicinal mushroom bioactive compounds
to the clinical evidence that suggests an important therapeutic role in cancer,
and other major diseases.
Download the monograph
The monograph is available for download on a chapter by chapter basis as PDF
documents. If you don't have a copy of Adobe Acrobat, you can download a copy
from their website at www.adobe.com/products/acrobat/readstep.html.
If you are having difficulty downloading the monograph - some of the sections
are quite large due to high quality images - please contact Cancer Research
UK via the email or phone details listed below to obtain a CD copy.
- Executive
Summary (33KB)
- Front
page (13KB)
- Preamble (16KB)
- Index (9KB)
- Chapter
1 - Introduction (37KB)
- Chapter
2 - Nature of fungi with special emphasis on mushrooms
(1,451KB)
- Chapter 3 - Medicinally important mushrooms
- Chapter
4 - Technology of mushroom cultivation (339KB)
- Chapter
5 - Extraction, development and chemistry of anti-cancer
compounds from medicinal mushrooms (400KB)
- Chapter
6 - Immunomodulatory activities of mushroom glucans and
polysaccharide-protein complexes in animals and humans (217KB)
- Chapter
7 - The role of polysaccarides derived from medicinal mushrooms
in cancer (134KB)
- Chapter
8 - Additional medicinal properties (85KB)
- Chapter
9 - Regulatory and safety criteria for functional foods
and dietary supplements and pharmaceutical medicines; the role
for medicinal mushrooms (68KB)
- Chapter
10 - Conclusions (50KB)
- Appendix
1 (604KB)
- Appendix
2 (13KB)
- Appendix
3 (18KB)
- Biographies (10KB)
- Acknowledgements (7KB)
Contacts at Cancer Research UK
For more information email John Smith at E.S.Clements@strath.ac.uk or
contact Richard Sullivan on Tel: 020 7242 0200 or richard.sullivan@cancer.org.uk.
> Return
to Medicinal Mushroom Articles
> Return Home
|